List of Beta Bionics, Inc. patents

Patents where

Current Assignee

Name

Beta Bionics, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11957876 Glucose control system with automated backup therapy protocol generation	Patent 11957876 was granted and assigned to Beta Bionics, Inc. on April, 2024 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11957876	April 16, 2024
‌ US Patent 11610661 Ambulatory medicament pump with safe access control	Patent 11610661 was granted and assigned to Beta Bionics, Inc. on March, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11610661	March 21, 2023
‌ US Patent 11688501 Ambulatory medicament pump with safe access control	Patent 11688501 was granted and assigned to Beta Bionics, Inc. on June, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11688501	June 27, 2023
‌ US Patent 11565041 Ambulatory medicament device with power saving mode	Patent 11565041 was granted and assigned to Beta Bionics, Inc. on January, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11565041	January 31, 2023
‌ US Patent 11633535 Ambulatory device and components thereof	Patent 11633535 was granted and assigned to Beta Bionics, Inc. on April, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11633535	April 25, 2023
‌ US Patent 10960137 Blood glucose control system with automated backup therapy protocol generation	Patent 10960137 was granted and assigned to Beta Bionics, Inc. on March, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	10960137	March 30, 2021
‌ US Patent 11581080 Ambulatory medicament pump voice operation	Patent 11581080 was granted and assigned to Beta Bionics, Inc. on February, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11581080	February 14, 2023
‌ US Patent 11571507 Ambulatory device and components thereof		Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11571507	February 7, 2023
‌ US Patent 11278661 Infusion system and components thereof	Patent 11278661 was granted and assigned to Beta Bionics, Inc. on March, 2022 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11278661	March 22, 2022
‌ US Patent 10940267 Blood glucose control system with real-time glycemic control optimization	Patent 10940267 was granted and assigned to Beta Bionics, Inc. on March, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	10940267	March 9, 2021
‌ US Patent 11587664 Glucose level control system with therapy customization		Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11587664	February 21, 2023
‌ US Patent 11610662 Medicament pumps and control systems for managing glucose control therapy data of a subject	Patent 11610662 was granted and assigned to Beta Bionics, Inc. on March, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11610662	March 21, 2023
‌ US Patent 11103638 Ambulatory medicament device with gesture-based control of medicament delivery	Patent 11103638 was granted and assigned to Beta Bionics, Inc. on August, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11103638	August 31, 2021
‌ US Patent 11123486 Switching blood glucose control system execution without interruption of therapy delivery	Patent 11123486 was granted and assigned to Beta Bionics, Inc. on September, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11123486	September 21, 2021
‌ US Patent 11129938 Ambulatory medical device update without interruption of therapy delivery	Patent 11129938 was granted and assigned to Beta Bionics, Inc. on September, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11129938	September 28, 2021
‌ US Patent 11594314 Modular blood glucose control systems	Patent 11594314 was granted and assigned to Beta Bionics, Inc. on February, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11594314	February 28, 2023
‌ US Patent 11123485 Blood glucose control system switching without interruption of therapy delivery	Patent 11123485 was granted and assigned to Beta Bionics, Inc. on September, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11123485	September 21, 2021
‌ US Patent 11045602 Ambulatory medical device with therapy data sharing via wireless wide area network	Patent 11045602 was granted and assigned to Beta Bionics, Inc. on June, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11045602	June 29, 2021
‌ US Patent 11497849 Ambulatory medicament device with power saving mode	Patent 11497849 was granted and assigned to Beta Bionics, Inc. on November, 2022 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11497849	November 15, 2022
‌ US Patent 11497852 Ambulatory medicament device with power saving mode	Patent 11497852 was granted and assigned to Beta Bionics, Inc. on November, 2022 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11497852	November 15, 2022
‌ US Patent 11116902 Blood glucose control system with control parameter modification	Patent 11116902 was granted and assigned to Beta Bionics, Inc. on September, 2021 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11116902	September 14, 2021
‌ US Patent D1032623 Display screen with animated graphical user interface	Patent D1032623 was granted and assigned to Beta Bionics, Inc. on June, 2024 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	D1032623	June 25, 2024
‌ US Patent 11515027 Cloud-connected ambulatory pump integration	Patent 11515027 was granted and assigned to Beta Bionics, Inc. on November, 2022 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	11515027	November 29, 2022
‌ US Patent D980857 Display screen with graphical user interface	Patent D980857 was granted and assigned to Beta Bionics, Inc. on March, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	D980857	March 14, 2023
‌ US Patent D980858 Display screen with transitional graphical user interface	Patent D980858 was granted and assigned to Beta Bionics, Inc. on March, 2023 by the United States Patent and Trademark Office.	Beta Bionics, Inc.	Beta Bionics, Inc.	United States Patent and Trademark Office	D980858	March 14, 2023

Results per page:

41 results

0 selected

41 results

0 selected